Neurosterix
PrivateLast Round
Series A
Apr 2, 2024
Est. Valuation
$98M
Total Funding Raised
$65M
Company Overview
Neurosterix is a biopharmaceutical company specializing in the development of innovative drugs for neurological disorders through a unique pharmacological approach known as allosteric modulation.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Mental Health, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurosterix Comps
Public and private peers based on sector, stage, and business model.
Neurosterix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 2, 2024 |
Neurosterix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A |
| Xontogeny | Series A |
| Acorn Bioventures | Series A |
Neurosterix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurosterix's valuation, stock price, and market status.
